{"transactions":[{"id":2041851,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T21:05:42.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":1700,"derivative":{"exercise_price":3.99,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001493152-23-002914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223002914/ownership.xml","form_type":"4"}},{"id":2422222,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-29T01:41:52.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 27, 2022, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":22100,"derivative":{"exercise_price":0.3701,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0001493152-22-002616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315222002616/ownership.xml","form_type":"4"}},{"id":2612719,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:46:18.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":4.55,"underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-21-050033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919121050033/doc4.xml","form_type":"4"}},{"id":2612718,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:46:18.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":4.43,"underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001209191-21-050033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919121050033/doc4.xml","form_type":"4"}},{"id":2612717,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:46:18.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":112441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":4.84,"underlying":"Common Stock","underlying_shares":112441},"source":{"system":"sec-edgar","filing":"0001209191-21-050033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919121050033/doc4.xml","form_type":"4"}},{"id":2612716,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:46:18.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":3.75,"underlying":"Common Stock","underlying_shares":13692},"source":{"system":"sec-edgar","filing":"0001209191-21-050033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919121050033/doc4.xml","form_type":"4"}},{"id":2612715,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:46:18.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":36069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":1.52,"underlying":"Common Stock","underlying_shares":36069},"source":{"system":"sec-edgar","filing":"0001209191-21-050033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919121050033/doc4.xml","form_type":"4"}},{"id":2622739,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-28T19:02:57.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4) of the shares underlying this stock option will vest and become exercisable on the first anniversary of the date of grant, and an additional 2.083% of the shares underlying the options will vest on the last day of each of the thirty-six (36) months that follow the first anniversary of the date of grant, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":0.87,"expiration_date":"2031-07-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-21-017971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315221017971/ownership.xml","form_type":"4"}},{"id":2866138,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-11T17:38:42.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest in quarterly installments over 4 years from the date of grant, provided continued employment with the Company on each such vesting date."}],"balance_after":105000,"derivative":{"exercise_price":4.55,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-21-009813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919121009813/doc4.xml","form_type":"4"}},{"id":3171658,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commerical Officer"}}],"security":"Stock Option Exercise (Right to Buy)","published_at":"2020-04-22T17:47:14.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest over four (4) years with 25% of the shares vesting on the one year anniversary of April 22, 2020 and the remaining 75% of the shares vesting in equal monthly installments for the following thirty-six (36) months, provided continued employment with the Company on each such vesting date."}],"balance_after":425000,"derivative":{"exercise_price":4.43,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001209191-20-025363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339469/000120919120025363/doc4.xml","form_type":"4"}},{"id":3649084,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-19T21:30:54.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":38700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."}],"balance_after":38700,"derivative":{"underlying":"Common Stock","underlying_shares":38700},"source":{"system":"sec-edgar","filing":"0001209191-19-011089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119011089/doc4.xml","form_type":"4"}},{"id":3649083,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-19T21:30:54.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":102800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 15, 2019. The shares underlying this option vest as to 25% of the shares on February 15, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":102800,"derivative":{"exercise_price":9.21,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":102800},"source":{"system":"sec-edgar","filing":"0001209191-19-011089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119011089/doc4.xml","form_type":"4"}},{"id":3883835,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":117530,"kind":"person","name":"Varadan Anand","position":1,"cik":"0001650456","reported_name":"Varadan Anand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2018-06-25T20:44:41.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 22, 2018.  The shares underlying this option vest as to 25% of the shares on June 22, 2019, with the remaining 75% vesting in 36 equal monthly installments."}],"balance_after":150000,"derivative":{"exercise_price":18.68,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-039409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118039409/doc4.xml","form_type":"4"}}]}